CNMC Criticizes Health Ministry's Tobacco Regulation Draft

Apr.11.2025
CNMC Criticizes Health Ministry's Tobacco Regulation Draft
CNMC criticizes draft health laws in Spain for impacting tobacco market, particularly e-cigarettes and nicotine pouches.

Key points:

The National Markets and Competition Commission (CNMC) of Spain has criticized the draft proposal by the Ministry of Health, stating that while it aims to address public health issues, it severely impacts competition in the tobacco market, particularly in the production and sale of e-cigarettes and nicotine pouches.

CNMC questions the lack of scientific basis for the proposed ban on e-cigarette and nicotine pouch flavors, as well as the proposal for standardized labeling and nicotine content limits. They also criticize the failure to explore alternative solutions that would have a lesser impact on competition.

The CNMC has warned that the draft legislation is not in line with EU regulations, which could cause trouble for businesses. It is recommended to strengthen public awareness campaigns and prohibit the sale of tobacco to minors, emphasizing that regulatory measures should adhere to good regulatory principles and be implemented through laws rather than royal decrees.


According to a report from the Huffington Post on April 10, the Spanish antitrust agency National Commission on Markets and Competition (CNMC) has strongly criticized the royal decree draft proposed by the Ministry of Health, which aims to regulate tobacco and related products.

 

The CNMC recognized the necessity of addressing public health issues caused by smoking but questioned the appropriateness of the proposed measures. According to the report, the proposed restrictions significantly impact competition in the tobacco market, particularly by placing restrictions on the production and sale of products such as e-cigarettes and nicotine pouches.

 

Criticism of CNMC focuses primarily on the ban on flavors other than tobacco in e-cigarettes and nicotine pouches. CNMC argues that this measure lacks empirical support and has not explored less restrictive alternatives that could minimize anti-competitive effects. Additionally, the report points out that the requirement for cigarettes and tobacco to have uniform packaging, as well as the limitation of nicotine pouches to a maximum of 0.99mg per pouch, lack sufficient scientific basis.

 

The CNMC also questioned the proportionality of the proposed measures, stating that other regulatory options that are equally effective but have less impact on competition were not adequately considered. The report suggests strengthening public awareness campaigns and banning the sale of tobacco to minors as feasible alternative solutions.

 

Another point of contention is the inconsistency with European regulations. The CNMC has warned that the proposed measures may diverge from future EU regulations that are currently under review by the European Commission, which could potentially add unnecessary trouble and complexity for manufacturers and retailers of tobacco products in Spain.

 

The report emphasizes that any measures restricting market competition must be in the public interest and adhere to principles of good regulation, such as necessity, proportionality, and non-discrimination. In addition, measures affecting business freedom should be implemented through laws rather than royal decrees.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | PLONQ Expands in China With New Shenzhen Hub to Accelerate R&D and Partnerships
Special Report | PLONQ Expands in China With New Shenzhen Hub to Accelerate R&D and Partnerships
On March 27, 2026, PLONQ officially opened its upgraded Shenzhen office, reinforcing its long-term commitment to China and marking a new phase of growth. As a leading vape brand in Russia, PLONQ is expanding into new product categories while strengthening R&D, engineering collaboration, and partnerships with Chinese companies. The Shenzhen office will accelerate product development, enhance cooperation with technology and manufacturing partners, and support future growth initiatives.
Apr.01
South Korea Moves Against Synthetic Nicotine Regulatory Gap as Three Companies Face Tobacco Business Act Probe
South Korea Moves Against Synthetic Nicotine Regulatory Gap as Three Companies Face Tobacco Business Act Probe
South Korea’s Ministry of Finance and Economy said on May 4 that it requested the Daejeon Metropolitan Police Agency and Gyeonggi Nambu Provincial Police Agency to investigate three sales companies on suspicion of violating the Tobacco Business Act.
May.06 by 2FIRSTS.ai
Exclusive | China Starts Mandatory National Standards Process for Heated Cigarettes and Nicotine Pouches
Exclusive | China Starts Mandatory National Standards Process for Heated Cigarettes and Nicotine Pouches
China has launched mandatory national standards work for heated cigarettes and nicotine pouches, further formalizing regulation of both categories. The move may help lay groundwork for future market entry, but does not signal imminent domestic commercialization.
Apr.15
Can hookah go institutional? A hookah company seeking to go public makes its case with capital, technology and regulation
Can hookah go institutional? A hookah company seeking to go public makes its case with capital, technology and regulation
2Firsts explored whether hookah can evolve into a more mature and governable category by interviewing Dubai-based hookah company AIR. AIR argues that strong margins, OOKA’s closed-system model and the prospect of differentiated regulation could support that shift. The larger question is whether this is simply AIR’s capital-markets narrative, or an early sign that competition, regulation and category boundaries in hookah are beginning to change.
Apr.02
FDA Filing Shows RIF Notices for 229 CTP Employees Were Largely Rescinded
FDA Filing Shows RIF Notices for 229 CTP Employees Were Largely Rescinded
A court declaration signed by FDA official Melanie M. Keller on March 24, 2026 detailed the status of previously issued reduction-in-force notices affecting employees at the Center for Tobacco Products (CTP).
Apr.01 by 2FIRSTS.ai
 Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
According to The Wall Street Journal, nicotine pouch brand Zyn has rapidly gained popularity across the Trump administration and conservative political circles, including among U.S. Health Secretary Robert F. Kennedy Jr.
Business
May.20